搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Ottawa Citizen
23 小时
Big breakthroughs for cancer patients thanks to immunotherapy treatment and research
The Ottawa Hospital is at the forefront when it comes to cancer immunotherapy research — from new therapies to clinicals ...
11 小时
Scientists Uncover Hidden Cause of Common Cancer Immunotherapy Side Effect
New insights into the impact of checkpoint inhibitors on the immune system may enhance cancer treatment strategies. A ...
labiotech
23 小时
The rise of cancer vaccines: A new era in immunotherapy
Delve into the expanding and diverse field of cancer vaccines with various approaches exploiting the immune system to fight ...
GlobalData on MSN
19 小时
Faron Pharma secures UK innovation passport for blood cancer immunotherapy
The MHRA has also granted approval to Faron Pharmaceuticals to conduct the BEXMAB trial of Clevegen in the UK.
News Medical on MSN
19 小时
New study explores heart risks of cancer immunotherapy
A cancer therapy that prompts the body's immune defenses against viruses and bacteria to attack tumors can make patients more ...
News Medical on MSN
12 小时
Spatial transcriptomics uncovers new treatment paths for triple-negative breast cancer
Study uses spatial transcriptomics to map intratumoral heterogeneity and microenvironmental dynamics in triple-negative ...
The American Journal of Managed Care
20 小时
Baseline Response Rates Inform Immunotherapy Sequencing in NSCLC
Investigators were seeking clarification on optimal sequencing of the immune checkpoint inhibitor atezolizumab following ...
4 小时
Understanding the Stages of Prostate Cancer: What Every Man Should Know
The TNM staging approach, which stands for tumour, nodes, and metastasis, is the most widely used method for staging prostate ...
1 小时
Oncolytics Biotech® Reports Completion of Initial Safety Phase Enrollment for GOBLET Trial ...
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...
4 小时
on MSN
‘Pioneering’ drug for rare eye cancer to be rolled out on NHS in England
Tebentafusp is the first treatment of its kind for uveal melanoma, which develops from cells in the middle layer of the eye, ...
33 分钟
on MSN
Mum's health warning as 'ugly' 5p sized mole turned out to be cancer
Claire underwent surgery to remove the melanoma and was told she was cancer-free but two years later she felt a lump in her ...
7 小时
BriaCell Therapeutics: Promising Developments in Cancer Treatment and Positive Outlook
BriaCell Therapeutics (BCT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Emily ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈